AB
ADPT icon

Amalgamated Bank’s Adaptive Biotechnologies ADPT Stock Holding History

Amalgamated Bank’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,695
Closed -$76K – 1639
2025
Q4 		$76K Buy
4,695
+703
+18% +$11.5K ﹤0.01% 1743
2025
Q3 		$60K Hold
3,992
– – ﹤0.01% 1791
2025
Q2 		$47K Hold
3,992
– – ﹤0.01% 1840
2025
Q1 		$30K Buy
3,992
+200
+5% +$1.54K ﹤0.01% 1936
2024
Q4 		$23K Hold
3,792
– – ﹤0.01% 2059
2024
Q3 		$19K Hold
3,792
– – ﹤0.01% 2142
2024
Q2 		$14K Hold
3,792
– – ﹤0.01% 2260
2024
Q1 		$12K Sell
3,792
-10,604
-74% -$41K ﹤0.01% 2339
2023
Q4 		$71K Sell
14,396
-1,129
-7% -$5.15K ﹤0.01% 2110
2023
Q3 		$85K Hold
15,525
– – ﹤0.01% 2053
2023
Q2 		$104K Buy
15,525
+3,883
+33% +$28.9K ﹤0.01% 2045
2023
Q1 		$103K Sell
11,642
-2,891
-20% -$25.5K ﹤0.01% 2043
2022
Q4 		$111K Buy
14,533
+320
+2% +$2.49K ﹤0.01% 2093
2022
Q3 		$101K Buy
14,213
+14
+0.1% +$132 ﹤0.01% 2140
2022
Q2 		$115K Sell
14,199
-10,714
-43% -$94.2K ﹤0.01% 2107
2022
Q1 		$346K Buy
24,913
+2,285
+10% +$35.9K ﹤0.01% 1707
2021
Q4 		$635K Buy
22,628
+2,944
+15% +$90.2K ﹤0.01% 1460
2021
Q3 		$669K Sell
19,684
-1,212
-6% -$43.8K 0.01% 1442
2021
Q2 		$854K Buy
20,896
+6,716
+47% +$261K 0.01% 1360
2021
Q1 		$571K Sell
14,180
-1,238
-8% -$67K 0.02% 908
2020
Q4 		$912K Sell
15,418
-6
-0% -$309 0.03% 599
2020
Q3 		$750K Buy
15,424
+671
+5% +$28.2K 0.03% 613
2020
Q2 		$714K Sell
14,753
-1,558
-10% -$56.8K 0.03% 606
2020
Q1 		$453K Buy
+16,311
New +$455K 0.01% 956

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Amalgamated Bank's ADPT Position: Q1 2026 in Review

Amalgamated Bank sold out of Adaptive Biotechnologies (ADPT) in Q1 2026, closing a stake of 4,695 shares — an estimated $76K sold.

Amalgamated Bank first reported a position in ADPT in Q1 2020 and held it in 24 quarters. The position peaked at $912K in Q4 2020. 296 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.

  • Amalgamated Bank reported no remaining Adaptive Biotechnologies position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 4,695 Adaptive Biotechnologies shares in Q1 2026, an estimated $76K.
  • Amalgamated Bank first reported a position in Adaptive Biotechnologies in Q1 2020 and held it in 24 quarters.
  • Amalgamated Bank's Adaptive Biotechnologies position peaked at $912K in Q4 2020.
  • 296 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.